Qure.ai's Clinical Decision Support System Aira Among World's First to Win Class IIb CE Certification
Built for frontline primary care in emerging economies, Aira is the first AI-powered clinical decision support system (CDSS) to combine documentation, workflow automation and analysis of patient EHR data with clinical decision-making under a single...
OCI N.V. statement regarding an open letter from shareholders
AMSTERDAM, Sept. 17, 2026 /PRNewswire/ -- OCI Global N.V. ("OCI" or the "Company") (Euronext: OCI) confirms that on 16 September 2026 it received from Oceanwood Capital Management LLP the attached open letter, written on behalf of a group of three...
FUJIFILM Business Innovation Celebrates 39 Award-Winning Entries at the Innovation Print Awards 2026 Asia-Pacific & Japan
TOKYO, Sept. 16, 2026 /PRNewswire/ -- FUJIFILM Business Innovation announces today the winners of the Innovation Print Awards 2026 Asia-Pacific & Japan (hereafter: IPA 2026 APJ) which celebrates creativity and technical excellence in production...
The Generation Essential Group's Receipt of NYSE Letter Regarding Class A Ordinary Shares Trading Price
NEW YORK and LONDON, Sept. 12, 2026 /PRNewswire/ -- The Generation Essentials Group (NYSE: TGE; LSE: TGE) ("TGE" or the "Company"), today announced that it has received a letter from the New York Stock Exchange (the "NYSE"), notifying the Company...
Accro Bioscience Announces IND Clearance from NMPA for Phase II/III Clinical Trial of AC-201, a Highly Selective TYK2/JAK1 Inhibitor for the Treatment of Non-Segmental Vitiligo
NEW YORK and SUZHOU, China, Sept. 8, 2026 /PRNewswire/ -- Accro Bioscience (Suzhou) Limited ("Accro") today announced that Shanghai Fosun Pharmaceutical Industrial Development Company Limited ("Fosun Pharma Industrial"), a subsidiary of its partner...
Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy
SHANGHAI, Sept. 8, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that it has recently received clearance from the U.S. Food and...
European Approval for Production Organisation Dutch Flying Car Company PAL-V
RAAMSDONKSVEER, Netherlands, Sept. 7, 2026 /PRNewswire/ -- Dutch company PAL-V has obtained its European Production Organisation Approval (POA). With this milestone, PAL-V now holds both the automotive and aviation production approvals required to...
China's Personalized mRNA Cancer Therapy Sector Accelerates: How Far Is It From a "DeepSeek Moment"?
BEIJING, Aug. 21, 2026 /PRNewswire/ -- Personalized mRNA cancer therapy has recently reached an important milestone. An international Phase 3 study in high-risk melanoma reported positive results, further supporting the clinical potential of...
Bracco Marks Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for VueJect®, the First Dedicated Ultrasound Contrast Delivery System to Support Cardiology Imaging
VueJect ® strengthens Bracco's integrated CEUS ecosystem by enabling more standardized, efficient contrast administration in cardiology imaging MILAN, Aug. 11, 2026 /PRNewswire/ -- Bracco Imaging today announced that VueJect®, its first dedicated...
AMTD IDEA's Receipt of NYSE Letter Regarding ADS Trading Price's Below Compliance Standards
PARIS and NEW YORK and SINGAPORE, Aug. 8, 2026 /PRNewswire/ -- AMTD IDEA Group (NYSE: AMTD; SGX: HKB) ("AMTD IDEA" or the "Company"), today announced that it has received a letter from the New York Stock Exchange (the "NYSE"), notifying the Company...